Gabapentin for disruptive behaviour in an elderly demented patient [1]

Drugs and Aging

Volumn 13, Issue 2, 1998, Pages 183-184

  Goldenberg, G ^a   Kahaner, K ^a   Basavaraju, N ^a   Rangu, S ^a  

^a Parker Jewish Institute for Health Care and Rehabilitation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

AGED; ALZHEIMER DISEASE; BEHAVIOR DISORDER; CASE REPORT; DEMENTIA; FEMALE; HUMAN; LETTER; LIMBIC SYSTEM; NEOCORTEX; PRIORITY JOURNAL; SUBSTANTIA NIGRA; THALAMUS;

EID: 0031679897     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199813020-00011     Document Type: Letter

References (10)

1. 1. JG Zimmer N Watson A Treat 1984 Behavioral problems among patients at skilled nursing facilities Am J Public Health 74 1118 20 6476166 10.2105/AJPH.74.10.1118 1:STN:280:DyaL2czgsVKhug%3D%3D Zimmer JG, Watson N, Treat A. Behavioral problems among patients at skilled nursing facilities. Am J Public Health 1984; 74: 1118–20
2. 2. LS Schneider VE Pollock SA Lyness 1990 A metaanalysis of controlled trials of neuroleptic treatment in dementia J Am Geriatr Soc 38 553 63 1970586 1:STN:280:DyaK3c3jslektg%3D%3D Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553–63
3. 3. PN Tairot R Erb A Leibovici 1994 Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study J Am Geriatr Soc 42 1160 6 Tairot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42: 1160–6
4. 4. A Mellow C Solano-Lopez S Davis 1993 Sodium valproate in the treatment of behavioral disturbances in dementia J Geriatr Psychiatry Neurology 6 205 9 1:STN:280:DyaK2c%2Fnt1SlsQ%3D%3D Mellow A, Solano-Lopez C, Davis S. Sodium valproate in the treatment of behavioral disturbances in dementia. J Geriatr Psychiatry Neurology 1993; 6: 205–9
5. 5. W Sandborn F Bendfeld R Hamdy 1995 Valproic acid for physically aggressive behavior in geriatric patients Am J Geriatr Psychiatry 3 239 42 10.1097/00019442-199522330-00007 Sandborn W, Bendfeld F, Hamdy R. Valproic acid for physically aggressive behavior in geriatric patients. Am J Geriatr Psychiatry 1995; 3: 239–42
6. 6. R Ryback L Ryback 1995 Gabapentin for behavioral dyscontrol agitation Am J Psychiatry 152 1399 7653702 1:STN:280:DyaK2Mzot1antw%3D%3D [letter] Ryback R, Ryback L. Gabapentin for behavioral dyscontrol agitation [letter]. Am J Psychiatry 1995; 152: 1399
7. 7. W Regan S Gordon 1997 Gabapentin for behavioral agitation in Alzheimer’s disease J Clin Psychopharmacol 17 59 60 9004063 10.1097/00004714-199702000-00015 1:STN:280:DyaK2s7lslOrtg%3D%3D [letter] Regan W, Gordon S. Gabapentin for behavioral agitation in Alzheimer’s disease [letter]. J Clin Psychopharmacol 1997; 17: 59–60
8. 8. C Taylor 1994 Emerging perspectives on the mechanism of action of gabapentin Neurology 44 Suppl. 5 S10 6 7517515 1:STN:280:DyaK2c3psVSktQ%3D%3D Taylor C. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44 Suppl. 5: S10–6
9. 9. R Ramsay 1994 Clinical efficacy and safety of gabapentin Neurology 44 Suppl. 5 S23 30 8022537 1:STN:280:DyaK2c3psVSkuw%3D%3D Ramsay R. Clinical efficacy and safety of gabapentin. Neurology 1994; 44 Suppl. 5: S23–30
10. 10. M Mclean 1994 Clinical pharmacokinetics of gabapentin Neurology 44 Suppl. 5 S17 22 8022536 1:STN:280:DyaK2c3psVSkug%3D%3D Mclean M. Clinical pharmacokinetics of gabapentin. Neurology 1994; 44 Suppl. 5: S17–22